Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 2
2010 2
2011 3
2012 2
2013 1
2014 4
2015 3
2017 1
2018 1
2021 5
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Predictors of the CD24/CD11b Biomarker among Healthy Subjects.
Shapira S, Aiger G, Ohayon A, Kazanov D, Mdah F, Shimon MB, Hay-Levy M, Banon L, Laskov I, Mashiah J, Lev-Ari S, Arber N. Shapira S, et al. Among authors: kazanov d. J Pers Med. 2021 Sep 21;11(9):939. doi: 10.3390/jpm11090939. J Pers Med. 2021. PMID: 34575716 Free PMC article.
A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond.
Shapira S, Ben Shimon M, Hay-Levi M, Shenberg G, Choshen G, Bannon L, Tepper M, Kazanov D, Seni J, Lev-Ari S, Peer M, Boubas D, Stebbing J, Tsiodras S, Arber N. Shapira S, et al. Among authors: kazanov d. EMBO Mol Med. 2022 Sep 7;14(9):e15997. doi: 10.15252/emmm.202215997. Epub 2022 Jul 13. EMBO Mol Med. 2022. PMID: 35776000 Free PMC article.
Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies.
Shapira S, Kazanov D, Mdah F, Yaakobi H, Herishanu Y, Perry C, Avivi I, Itchaki G, Shacham-Abulafia A, Raanani P, Hay-Levy M, Aiger G, Mashiah J, Lev-Ari S, Arber N. Shapira S, et al. Among authors: kazanov d. J Pers Med. 2021 Jul 27;11(8):724. doi: 10.3390/jpm11080724. J Pers Med. 2021. PMID: 34442367 Free PMC article.
Of mice and men: a novel dietary supplement for the treatment of ulcerative colitis.
Shapira S, Leshno A, Katz D, Maharshak N, Hevroni G, Jean-David M, Kraus S, Galazan L, Aroch I, Kazanov D, Hallack A, Becker S, Umanski M, Moshkowitz M, Dotan I, Arber N. Shapira S, et al. Among authors: kazanov d. Therap Adv Gastroenterol. 2017 Nov 28;11:1756283X17741864. doi: 10.1177/1756283X17741864. eCollection 2018. Therap Adv Gastroenterol. 2017. PMID: 29383023 Free PMC article.
Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cells.
Shapira S, Finkelshtein E, Kazanov D, Naftali E, Stepansky I, Loyter A, Elbirt D, Hay-Levy M, Brazowski E, Bedny F, Dekel R, Hershkovitz D, Blachar A, Wolf I, Arber N. Shapira S, et al. Among authors: kazanov d. Oncogene. 2021 Jun;40(22):3815-3825. doi: 10.1038/s41388-021-01779-5. Epub 2021 May 6. Oncogene. 2021. PMID: 33958722 Free PMC article.
CD24 gene polymorphism--a novel prognostic factor in esophageal cancer.
Sadot E, Kraus S, Stein M, Naboishchikov I, Toledano O, Kazanov D, Arber N, Kashtan H. Sadot E, et al. Among authors: kazanov d. Int J Biol Markers. 2014 Mar 24;29(1):e49-54. doi: 10.5301/jbm.5000071. Int J Biol Markers. 2014. PMID: 24474454 Free article.
Increased expression of CD24 in nonmelanoma skin cancer.
Miller E, Shapira S, Gur E, Naumov I, Kazanov D, Leshem D, Barnea Y, Meshiach Y, Gat A, Sion D, Arber N, Kraus S. Miller E, et al. Among authors: kazanov d. Int J Biol Markers. 2012 Dec 27;27(4):e331-6. doi: 10.5301/JBM.2012.9935. Int J Biol Markers. 2012. PMID: 23250778 Free article.
24 results